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PURPOSE. A majority of experimental data on dry eye disease (DED) immunopathogenesis have
been derived from a murine model of DED that combines desiccating environmental stress
with systemic muscarinic acetylcholine receptor (mAChR) inhibition. However, to our
knowledge the effects of pharmacologic mAChR blockade on the pathogenesis of
experimental DED have not been evaluated systemically. The purpose of our study was to
investigate the differential effects of desiccating environmental stress and mAChR inhibition
on the pathogenesis of DED.
METHODS. DED was induced in female C57BL/6 mice by exposure to a desiccating
environment in the controlled-environment chamber or to systemic scopolamine, or by
performing extraorbital lacrimal gland excision. Clinical disease was assessed using corneal
fluorescein staining (CFS) and the cotton thread test (CTT). Corneal CD11bþ and conjunctival
CD3þ T-cell infiltration were evaluated by flow cytometry. T-cells from draining cervical
lymph nodes (CLN) and distant inguinal lymph nodes (ILN) were analyzed for Th1, Th2,
Th17, and Treg responses by flow cytometry and ELISA.
RESULTS. Desiccating environmental stress and systemic mAChR blockade induced similar
clinical signs of DED. However, desiccating environmental stress imparted higher conjunctival
CD3þ T-cell infiltration, and greater Th17-cell activity and Treg dysfunction than mAChR
blockade, while mAChR blockade decreased tear secretion to a greater extent than
desiccating environmental stress. Systemic mAChR blockade attenuated Th17 activity and
enhanced Th2 and Treg responses without affecting Th1 activity.
CONCLUSIONS. In vivo inhibition of mAChRs variably affects CD4þ T-cell subsets, and
desiccating environmental stress and systemic mAChR blockade induce DED through
different primary pathogenic mechanisms.
Keywords: dry eye disease, controlled-environment chamber, scopolamine, CD4þ T-cells
Dry eye disease (DED) is the most common reason forpatient presentation to ophthalmologists and optometrists
in the United States.1,2 Clinical studies have demonstrated that
CD4þ T helper (Th)–cell infiltration of the ocular surface is a
prevalent finding in DED.3 Experimental evidence suggests that
DED is an immunoinflammatory disorder of the ocular surface
that involves effector Th-cell responses and regulatory T-cell
(Treg) dysfunction.4–7 An experimental model used commonly
to study the immunopathogenesis of DED utilizes a combina-
tion of desiccating environmental stress and pharmacologic
inhibition of aqueous tear secretion.4,8,9 Desiccating environ-
mental conditions are produced using either an air blower or a
controlled-environment chamber (CEC) that allows for the
continuous regulation of environmental conditions, such as
temperature, humidity, and airflow.10 Exposing the ocular
surface to dry conditions (e.g., low humidity and high airflow)
increases tear evaporation and leads to the clinical signs of
DED. Aqueous tear deficiency is induced by administering
scopolamine (SCP), a tropane alkaloid that antagonizes
muscarinic activity.
Scopolamine inhibits acetylcholine (ACh)-mediated stimula-
tion of the lacrimal gland by blocking muscarinic ACh receptors
(mAchR),11,12 thereby mimicking anti-M3 antibody-mediated
Sjo¨gren’s syndrome.13 However, an independent, nonneuronal
cholinergic system that modulates T-cell responses has been
identified,14 necessitating the elucidation of SCP’s pharmaco-
logic effects on T-cells. It has been suggested that ACh regulates
immune-neurohumoral crosstalk through its activity on T-cell–
expressed mAChR and nicotinic ACh receptors.15 The activa-
tion of mAChRs has been shown to enhance intracellular Ca2þ
signaling and upregulate c-fos mRNA expression,16 increase
phytohemagglutinin-induced IL-2 production,17 enhance T-cell
proliferation,18 and decrease IFN-c synthesis.19 Conversely,
inhibition of mAChRs decreases IL-6 secretion20 and suppresses
leukocytic infiltration.18
To date, to our knowledge the role of mAChRs on each
individual CD4þ T-cell subset in vivo has yet to be determined.
Herein, we systemically investigated the effects of systemic
mAChR blockade on Th1, Th2, Th17, and Treg responses.
Furthermore, we analyzed the differential effects of desiccating
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Female C57BL/6 mice 6 to 8 weeks old (Charles River
Laboratories, Wilmington, MA) were used for this study. All
animal experiments were approved by the Institutional Animal
Care and Use Committee, and adhered to the Association for
Research in Vision and Ophthalmology (ARVO) Statement for
the Use of Animals in Ophthalmic and Vision Research.
DED Induction
DED was induced in mice by either placing them in the CEC
with a relative humidity below 15%, airflow of 10 L/min, and a
constant temperature of 218C to 238C for 14 days,8 or
subcutaneously administering 0.1 mL of 5 mg/mL scopolamine
hydrobromide (SCP, formulated in normal saline; Sigma-Aldrich
Corp., St Louis, MO) three times per day (9 AM, 1 PM, and 5
PM) on the dorsal surface of mice. For comparison of different
models of tear-deficiency dry eye, DED was induced in one
group by simultaneous SCP administration and CEC exposure
(SCPþCEC), and in the other group by performing extraorbital
lacrimal gland excision (LGE) and CEC exposure (LGEþ CEC).
Untreated age and sex-matched mice maintained in the
standard vivarium were used as normal controls. To perform
extraorbital lacrimal gland excision, mice were anesthetized,
and the surgical site was marked approximately halfway
between the lateral canthus and ear pinna. The extraorbital
lacrimal gland was removed with blunt dissection, the
cutaneous wound was closed with a single 8-0 nylon suture,
and antibiotic ointment was applied to the surgical site. Several
potential adverse effects of this procedure received consider-
ation, including parotid gland damage (body weight loss
associated with difficulty masticating or swallowing), facial
artery damage (intraoperative or postoperative bleeding), facial
nerve damage (blink reflex), and wound infection (wound
inspection and behavior monitor). No cases with these adverse
effects were identified in the study.
Clinical Evaluation
Corneal fluorescein staining (CFS) was used to evaluate corneal
epithelial damage caused by DED. A dose of 1 lL of 2.5%
fluorescein (Sigma-Aldrich Corp.) was applied into the lateral
conjunctival sac of the mice, and 3 minutes later their corneas
were examined using a slit-lamp biomicroscope (Topcon SL-
D7; Topcon Corp., Tokyo, Japan) under cobalt blue light.
Punctate staining was recorded in a masked fashion using the
National Eye Institute grading system, scoring 0 to 3 for each of
five areas of the cornea: central, superior, inferior, nasal, and
temporal.21 The cotton thread test (CTT) was used to evaluate
aqueous tear production as described previously.10 Briefly, a
phenol red thread (Zone-Quick; Lacrimedics, Eastsound, WA)
was placed in the lateral canthus of the conjunctival fornix of
the right eye for 30 seconds after excess tears had been
removed for a standard time of 4 seconds, and tear distance (in
millimeters) was read under a microscope (Topcon SL-D7;
Topcon Corp.). In SCP-treated mice, the CTT was performed
half an hour before the SCP injection in the afternoon.
Flow Cytometry Analysis
Tissues were collected at day 14 of DED induction. Single-cell
suspensions were prepared from cornea and conjunctiva by
collagenase digestion. Briefly, tissues were removed and cut
into small fragments, followed by digestion with 2 mg/mL
collagenase type IV (Sigma-Aldrich Corp.) and 0.05 mg/mL
DNase I (Roche, Basel, Switzerland) for 1 hour at 378C with
agitation. The suspension then was triturated through a 30-
gauge needle to homogenize the remaining tissue and filtered
through a 70-lm cell strainer (BD Biosciences, Bedford, MA).
Corneal cells then were double-stained with PE-Cy5-conjugated
anti-CD45 and Alexfluo 488-conjugated anti-CD11b (eBio-
science, San Diego, CA). Conjunctival cells were stained with
PE-conjugated anti-CD3e (eBioscience). Single-cell suspensions
were prepared from lymph nodes using a 70 lm cell strainer.
For Treg analysis, cells were stained with FITC-conjugated anti-
CD4, PE-conjugated anti-CD25, and PE-Cy5–conjugated anti-
Foxp3 (eBioscience). For effector T-cell analysis, cells first were
stimulated with phorbol 12-myristate 13-acetate and ionomycin
(Sigma-Aldrich Corp.) in the presence of GolgiStop (BD
Biosciences), and then stained with FITC-conjugated anti-
CD4. After fixation with IC Fixation Buffer (eBioscience), cells
were permeabilized with Permeabilization Buffer (eBioscience)
and stained with APC-conjugated anti–IFN-c, PE-Cy7–conjugat-
ed anti–IL-4, and PE-conjugated anti–IL-17A (eBioscience).
Control samples were stained with appropriate isotype-
matched control antibodies (eBioscience). Stained cells were
examined on an LSR II flow cytometer (BD Biosciences) and
the results were analyzed using Summit v4.3 software (Dako
Colorado, Inc., Fort Collins, CO).
Treg Suppression Assay
The suppressive function of Tregs was examined as described
previously.6 Briefly, CD4þCD25þ Tregs and responder CD4þ T
(Tresp) cells were isolated from lymph nodes by magnetic
separation using Treg and CD4þ T-cell isolation kits (Miltenyi
Biotec, Inc., Auburn, CA). The purity of sorted cells was >95%,
and 97% of CD4þCD25þTreg cells were Foxp3þ in all the groups
as confirmed by flow cytometry analysis. Tresp cells (13 105)
from normal mice were cocultured with Treg cells (5 3 104)
from different experimental groups, T-cell–depleted syngeneic
splenocytes (13 105, by CD90þ depletion kit; Miltenyi Biotec,
Inc.) from normal mice, and 1 g/mL anti-CD3 Ab for 3 days.
Proliferation of CD3-stimulated Tresp cells without adding Treg
cells was considered control proliferation with 0% suppression.
Proliferation was measured using the BrdU proliferation kit
(Millipore, Billerica, MA), and percentage of suppression was
calculated using the following formula: %suppression¼ ([Tresp
proliferation without Treg  Tresp proliferation with Treg]/
Tresp proliferation without Treg)3 100.

FIGURE 1. Evaluation of DED. DED was induced using either a CEC or systemically administered SCP. (A) Corneal epithelial damage assessment by
standard corneal fluorescein staining scores. Representative images of normal (day 0) and dry eye (day 14) corneas from each group are shown on
the left. The corneal epithelial defect is exhibited as green staining (white arrowhead). *P < 0.05. (B) Aqueous tear production assessment by CTT.
Representative images of normal (day 0) and dry eye (day 14) tear measurement from each group are shown on the left. The tear production is
measured as the length of red staining (distance between the two blue arrowheads in each image). Data shown represent the mean 6 SEM of a
single representative experiment (12 eyes from 6 mice per group). *P < 0.05 between CEC and SCP groups. (C) Flow cytometry analysis of corneal
CD11bþ cells. A total of 12 corneas was pooled in each group. Percentages represent CD45þCD11bþ cells as a proportion of total corneal cells. (D)
Flow cytometry analysis of conjunctival CD3þ T-cells. A total of 12 conjunctivae was pooled in each group. Percentages represent CD3þ T-cells as a
proportion of total conjunctival cells.
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Cytokine Expression Analysis
Enriched CD4þ T-cells from lymph nodes were isolated by
magnetic separation using CD4 T-cell isolation kit (Miltenyi
Biotec, Inc.), and stimulated with PMA and ionomycin for 24
hours. The cytokines IFN-c, IL-4, and IL-17 in cell supernatant
were assayed with commercial ELISA kits (eBioscience).
Statistical Analyses
An unpaired, 2-tailed Student’s t-test was used for data analysis
with data normality examined by NormQuant.xls.22 Differenc-
es were considered significant at P < 0.05.
RESULTS
Clinical Signs of DED Can Be Induced Effectively
Using the CEC or SCP Alone
The DED-inducing effects of the controlled-environment
chamber (CEC) alone have been reported;8 however, the
ability of SCP alone to induce clinically evident DED has not
been investigated to our knowledge. To determine if SCP alone
can induce experimental DED as effectively as the CEC, mice
were challenged with either CEC or SCP alone, and evaluated
with CFS and CTT on days 0 (before challenge), 3, 7, 10, and
14. CEC and SCP generated comparable CFS scores and
patterns at all time points except day 3, when the CEC group
exhibited a significantly higher CFS score than SCP group (Fig.
1A). The more peripheral corneal staining patterns usually are
seen in mild to moderate DED as presented here, while
peripheral and central corneal staining is observed commonly
in more severe DED.8 Aqueous tear production measurements
revealed that SCP significantly inhibited tear secretion at early
and late time points, while the CEC only caused a slight tear
reduction at early time points that was not conserved at later
time points (Fig. 1B). Examination of the ocular surface
inflammation on day 14 revealed that SCP-induced DED was
accompanied by lower corneal infiltration of CD11bþ cells (Fig.
1C) and lower conjunctival infiltration of CD3þ T-cells (Fig. 1D)
in comparison with CEC-induced DED.
CEC and SCP-Induced DED Exhibit Comparable
Th1 Responses
Draining cervical lymph nodes (CLN), including cervical and
submandibular lymph nodes, are the primary sites of autore-
active T-cell priming and expansion in DED.5,6 Therefore,
distant inguinal lymph nodes (ILN) were selected to determine
the systemic effects of SCP on CD4þ T-cells. After 14 days of
DED induction, ILN were harvested and examined using flow
cytometry to measure T-cell frequency and ELISA to measure
cytokine production. There were no significant differences in
ILN IFN-cþCD4þ T-cell frequency (Fig. 2A) or IFN-c production
(Fig. 2B) between the CEC, SCP, and na¨ıve mice. Whereas,
performing the same examinations on the CLN showed that
there was a significant increase in IFN-c production (2-fold) in
the CEC and SCP groups compared to the normal group (Fig.
2D); however, there were no significant differences in IFN-
cþCD4þ T-cell frequencies (Fig. 2C), and this can be due to the
enhanced cytokine secretion of IFN-cþCD4þ T-cells, which are
activated in DED draining lymph nodes. Furthermore, there
were no significant differences in IFN-c expression between
the CEC and SCP groups.
SCP Enhances Th2 Activity
Next, ILN and CLN were analyzed for Th2 responses. Although
there were no significant changes in either IL-4 þCD4þ T-cell
frequency or IL-4 level in CEC-derived ILN compared to normal
ILN, IL-4 þCD4þ T-cell frequency and IL-4 levels in SCP-derived
ILN significantly increased relative to normal levels (Figs. 3A,
3B). The same findings were observed in the CLN of SCP-
treated mice (Figs. 3C, 3D), suggesting that these Th2
responses were the result of systemic SCP administration
rather than the immune response to DED.
SCP Inhibits Th17 Responses
Th17 responses in the ILN and CLN of CEC- and SCP-treated
mice were evaluated. In CEC-derived ILN, neither the IL-
17þCD4þ T-cell frequency nor the IL-17 level differed signifi-
cantly from normal. However, IL-17 þCD4þ T-cell frequency
(Fig. 4A) and IL-17 level (Fig. 4B) were decreased dramatically
FIGURE 2. Th1 cell response evaluation. Distant ILN (A, B) and DED draining CLN (C, D) were harvested for Th1 frequency analysis and signature
cytokine level quantification. The experiment was repeated twice with 6 animals in each group. (A, C) Representative flow cytometry dot plots
from one of the experiments are located on the left. Percentages represent Th1 cells as a proportion of total CD4þT-cells in normal, CEC-challenged,
and SCP-challenged mice. The fold changes (mean 6 SD) of Th1 cell frequencies in CEC and SCP groups relative to normal group are summarized
for all the repeated experiments, and presented as a bar graph located on the right. (B, D) IFN-c protein levels in each group were measured with
ELISA. Data represent the mean 6 SD of 6 mice from one representative experiment. *P < 0.05 when compared to normal group.
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in SCP-derived ILN compared to normal ILN. In contrast, in
DED draining CLN, the CEC and SCP groups exhibited
increased IL-17þCD4þ T-cell frequencies (Fig. 4C) as well IL-
17 levels (Fig. 4D) compared to the normal group. Further-
more, IL-17þCD4þ T-cell frequency and IL-17 level were higher
in the CEC group than the SCP group (Figs. 4C, 4D).
SCP Promotes the Suppressive Function of Tregs
Given the recently recognized importance of Treg function in
the pathogenesis of DED,6 the effects of SCP on this immunity-
restricted T-cell population were assessed. First, the frequen-
cies of CD4þCD25þFoxp3þ Tregs in ILN were evaluated, but
there were no significant differences between groups (Fig. 5A).
Next, using an in vitro coculture suppression assay, the
potential of purified Tregs to suppress CD4þ T-cell proliferation
was compared between CEC- and SCP-treated mice. CEC-
derived ILN Tregs suppressed equivalently to normal Tregs;
however, SCP-derived ILN Tregs demonstrated significantly
increased suppressive activity (Fig. 5B), suggesting that a
functional imbalance between Tregs and effector Th (especial-
FIGURE 3. Th2 cell response evaluation. Distant ILN (A, B) and DED draining CLN (C, D) were harvested for Th2 frequency analysis and signature
cytokine level quantification. The experiment was repeated twice with 6 animals in each group. (A, C) Representative flow cytometry dot plots
from one of the experiments are located on the left. Percentages represent Th2 cells as a proportion of total CD4þ T-cells for normal, CEC-
challenged, and SCP-challenged mice. The fold changes (mean 6 SD) of Th2 cell frequencies in CEC and SCP groups relative to normal group are
summarized for all the repeated experiments, and presented as a bar graph located on the right. (B, D) IL-4 protein levels in each group were
measured with ELISA. Data represent the mean 6 SD of 6 mice from one representative experiment. *P < 0.05 when compared to normal group.
FIGURE 4. Th17 cell response evaluation. Distant ILN (A, B) and DED draining CLN (C, D) were harvested for Th17 frequency analysis and signature
cytokine level quantification. The experiment was repeated twice with 6 animals in each group. (A, C) Representative flow cytometry dot plots
from one of the experiments are located on the left. The indicated percentages of Th17 cells as a proportion of total CD4þ T-cells were measured in
normal, CEC-challenged, and SCP-challenged mice. The fold changes (mean 6 SD) of Th17 cell frequencies in CEC and SCP groups relative to
normal group are summarized for all the repeated experiments, and presented as a bar graph located on the right. (B, D) IL-17 protein levels in
each group were measured with ELISA. Data represent the mean 6 SD of 6 mice from one representative experiment. *P < 0.05 when compared to
normal group. †P < 0.05 between CEC and SCP groups.
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ly Th17) cells was caused by SCP. The same analysis on CLN
revealed that Tregs from the CEC and SCP groups exhibited
defects in quality of the Treg response (suppression efficiency,
Fig. 5D), but not in the quantity of Tregs (cell frequency, Fig.
5C), and that Treg dysfunction was greatest in the CEC-induced
group (Fig. 5D).
LGE Induces More Severe DED Than SCP
To confirm further the in vivo effect of SCP on CD4þT-cells and
DED severity, LGE was performed to induce lacrimal hypose-
cretion without affecting the systemic immune response.
Based on CFS scoring, LGE combined with CEC (LGE þ CEC)
induced more severe disease than SCP combined with CEC
(SCPþ CEC, Fig. 6A). At the end of the disease induction (day
14), DED draining CLN from both groups were harvested, and
analyzed for IFN-c and IL-17 levels. Both groups showed
significantly increased IFN-c and IL-17 levels compared to
normal controls. There was no significant difference in IFN-c
levels between the LGE þ CEC and SCP þ CEC groups;
however, the LGE þ CEC group demonstrated a significantly
higher level of IL-17 than SCP þ CEC group (Fig. 6B).
DISCUSSION
In our study, we showed that the in vivo inhibition of mAChRs
variably affects CD4þ T-cell subsets. Furthermore, by compar-
ing various models of experimental DED, we demonstrated
that desiccating environmental stress and systemic mAChR
blockade induce DED through different primary pathogenic
mechanisms.
Historically, DED was thought to be the result of inadequate
tear film quantity or quality alone. However, the definition of
DED since has been modified to recognize the importance of
tear film hyperosmolarity and ocular surface inflammation in
the pathogenesis of DED.23 These changes came about in part
due to clinical and experimental studies that implicated
immunity in the pathogenesis of DED. A majority of the
experimental studies investigating the immunopathogenesis of
DED have used a combination of desiccating environmental
stress (e.g., CEC) and pharmacologic tear inhibition (e.g., SCP)
to induce murine DED.4–9 A previous study showed that SCP
not only reduced lacrimal secretion, but induced lacrimal gland
inflammation.24 Given the potential effects of SCP on immune
responses, it is vital to determine the effects of mAChR
blockade on pathogenic immune responses in this model of
experimental DED. To elucidate this, we investigated CD4þ T-
cell responses in disease-related draining CLNs and disease-
independent distant ILNs.
Our data demonstrated that there are no significant changes
in Th1, Th2, Th17, or Treg responses in the distant ILNs of
CEC-induced DED mice, indicating that distant ILNs are not
involved actively in the localized DED immune response.
Therefore, in DED induced by systemic mAChR blockade,
changes in immune activity observed in the ILN reflect the
direct pharmacologic effects of mAChR on the immune system.
Specifically, systemic administration of SCP leads to upregu-
lated Th2 (IL-4) and Treg (suppressive activity) responses,
downregulated Th17 (IL-17) responses, and unchanged Th1
(IFN-c) responses in the ILN. These results differed somewhat
from the findings of Qian et al. regarding the muscarinic
cholinergic regulation of CD4þ T-cell differentiation.25 They
reported that in vitro stimulation of CD4þ T-cells with the
mAChR agonist muscarine increases IL-17 production and
decreases IFN-c secretion without affecting IL-4 levels, and
these effects are abolished with the administration of the
mAChR antagonist atropine. These in vitro results and our in
vivo results demonstrate that mAChR blockade leads to Th17
inhibition; however, the findings regarding Th1 and Th2
responses are not consistent between the two studies. In
another in vitro experiment, the mAChR agonist pilocarpine
has been shown to decrease IFN-c synthesis by human
mononuclear leukocytes.19 However, in the combined M1
and M5 mAChR knockout mice, there is no significant change
in IFN-c secretion, but there is decreased IL-6 production.20
This is in accordance with our demonstration that SCP does
not affect Th1 response. Since IL-6 is a critical differentiation
factor for the generation of Th17 cells,26 the downregulated
Th17 response by SCP administration may be due to the
FIGURE 5. Treg response evaluation. Distant ILN (A, B) and DED draining CLN (C, D) were harvested for Treg frequency and functional analysis.
The experiment was repeated twice with 6 animals in each group. (A, C) Representative flow cytometry dot plots (Treg percentage of total CD4þ T-
cells) from one of the experiments are displayed on the left. The fold changes (mean 6 SD) of Treg cell frequencies in CEC and SCP groups relative
to normal group are summarized for all the repeated experiments and presented as a bar graph located on the right. (B, D) Suppression of T-cell
proliferation by Tregs was assessed using an in vitro suppression assay as shown on the right. Data are presented as the mean 6 SD of 6 mice and
each sample was measured in triplicates. *P < 0.05 when compared to normal group. †P < 0.05 between CEC and SCP groups.
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decreased expression of IL-6. In addition, our study has
revealed that mAChR blockade enhances the suppressive
capacity of Tregs, suggesting that Th17 inhibition also can
result from the restriction imposed by Tregs.27 In summary, our
findings indicated that mAChR blockade facilitates the devel-
opment of Th2 and Treg responses, and inhibits Th17
polarization. These findings are similar to the reported effects
of nicotine, a nicotinic AChR agonist, on immune response,
including suppression of the Th1 and Th17 lineages, and
promotion of the Th2 lineage,28 as well as increased
suppressive capacity of Tregs.29
In the DED draining CLN, CEC- and SCP-induced models
exhibit increased Th1 and Th17 responses, accompanied by
deficient Treg suppression. These findings are consistent with
previous studies that combined desiccating stress (e.g., CEC)
and SCP-induced DED.5–7 However, immune responses in the
draining CLN of CEC and SCP-induced models differ (Fig. 7).
SCP-induced DED demonstrated significantly lower Th17
responses and higher Treg activity than CEC-induced DED,
and these alterations are attributable to the pharmacologic
effects of SCP on CD4þ T-cells. Therefore, the immune
responses that occur in the CLN of SCP-induced DED mice
can be considered the result of the ocular disease and drug
effects. The increased Th2 responses observed in the CLN of
SCP-induced DED are attributable to the pharmacologic effects
of SCP, and are thought to be unrelated to the immunopatho-
genesis of DED. Corresponding to the relatively lower effector
T-cell responses in the disease-draining lymph nodes, SCP-
induced DED exhibits fewer CD11bþ and T-cell infiltration in
the ocular surface than CEC-induced DED, which can be due to
the lower numbers of effector T-cells generated in the CLN, as
well as the suppressive effect of mAChR blockade on
monocytes and T-cell migration.18 Although SCP induces
weaker disease-promoting inflammatory immune responses,
it generates comparable levels of clinical severity as the CEC, as
demonstrated by comparable CFS scores. CFS is the recom-
mended method of measuring ocular surface epithelial damage
and the resultant barrier disruption,21 which is the character-
istic pathology of DED at the cellular level.30 This most likely is
due to SCP-induced lacrimal hyposecretion, which is an
important factor in the pathogenesis of DED (Fig. 7). To
confirm the role of SCP further in the immunopathogenesis of
DED, mice were subjected to LGE to mimic the aqueous tear
deficiency induced by systemic administration of SCP. LGE has
been reported to induce dry eye in rats by reducing tear
secretion.31 In our study, LGE and SCP caused tear excretory
dysfunction; however, in comparison with SCP, LGE caused a
more robust localized immune response without affecting
systemic immunity. As a result, LGEþCEC induces more severe
disease than SCP þ CEC, as correlated by the higher Th17
responses measured using the LGE þ CEC model (Fig. 6).
FIGURE 6. Disease severity and pathogenic T-cell responses in DED induced by physical removal versus pharmacologic blockade of lacrimal gland.
SCP and LGE groups were placed in the CEC for 14 days, and DED draining CLN were collected for examination of Th1 and Th17 responses. (A)
Clinical disease severity was evaluated with CFS. Data are the mean 6 SEM of five mice at each time point. (B) IL-17 and IFN-c levels in CLN detected
by ELISA. Data are presented as the mean 6 SD of five mice. *P < 0.05 when compared to normal group. †P < 0.05 between SCP and LGE groups.
FIGURE 7. Pathogenic mechanisms compared between CEC- and SCP-
induced DED. CEC induces clinically evident DED as effectively as SCP.
Regarding disease-promoting factors, CEC and SCP led to comparable
Th1 responses; however, CEC induced a much stronger Th17 response.
Additionally, the CEC did not lead to significant tear deficiency. In
contrast, SCP suppressed exocrine function and resulted in notable
tear deficiency. Regarding disease inhibiting factors, the CEC impairs
Treg functioned dramatically; while SCP-induced DED showed much
less damage to Treg function. , promotion; a, inhibition. Symbol
thickness indicates intensity.
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In summary, we presented novel findings regarding the in
vivo effects of mAChR blockade on various CD4þT-cell subsets.
Although desiccating environmental stress and mAChR block-
ade induced similar levels of clinical disease, they did so
through different primary pathogenic mechanisms. Systemic
mAChR blockade promotes pathogenic aqueous tear deficien-
cy, while simultaneously inhibiting pathogenic immune re-
sponses. These findings reinforce the idea that DED models are
not necessarily interchangeable, and care should be taken in
choosing the model that will yield the most meaningful study
results.
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